ZMapp
id:
zmapp-188-767672
title:
ZMapp
text:
ZMapp is an experimental biopharmaceutical drug comprising three chimeric monoclonal antibodies under development as a treatment for Ebola virus disease. Two of the three components were originally developed at the Public Health Agency of Canada's National Microbiology Laboratory (NML), and the third at the U.S. Army Medical Research Institute of Infectious Diseases; the cocktail was optimized by Gary Kobinger, a research scientist at the NML and underwent further development under license by Ma
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental treatment for Ebola virus disease
original url:
https://en.wikipedia.org/wiki/ZMapp
date created:
2014-08-05T06:42:18Z
date modified:
2024-09-08T20:36:34Z
main entity:
{"identifier":"Q17486688","url":"https://www.wikidata.org/entity/Q17486688"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/9a/Monoclonals.png","width":1308,"height":1464}
fields total:
13
integrity:
16